主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
FEMY
#3687
Femasys Inc. Common Stock
0.5
7
0.00%
版块:
基础:
利润货币:
日范围
年范围
日变化
0.00%
每月变动
-3.39%
6个月变化
+50.00%
年变化
-65.45%
前一天收盘价
0.5
7
Open
0.5
7
Bid
Ask
Low
0.5
7
High
0.5
7
交易量
5
市场
股票
医疗保健
FEMY
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
11.8 M
11.87 M
22.1 M
27.15 M
—
Valuation ratios
Enterprise value
21.25 M
-2.28 M
604.26 K
26.41 M
100.93 M
Price to earnings ratio
-3.48
-0.94
-1.09
-1.29
-4.28
Price to sales ratio
22.19
8.82
14.5
15.04
48.96
Price to cash flow ratio
-3.3
-0.99
-1.38
-1.26
-4.41
Price to book ratio
0.99
0.7
0.85
10.63
14.87
Enterprise value to EBITDA ratio
-2.75
0.21
-0.04
-1.62
-5.92
Profitability ratios
Return on assets %
-0.26
-0.67
-0.51
-1.51
-1.45
Return on equity %
-0.29
-0.75
-0.78
-8.17
-9.14
Return on invested capital %
-929.89
-1 343.28
-1 386.43
-919.33
-721.05
Gross margin %
68.6
63.36
64.54
66.55
253.62
Operating margin %
-706.7
-961.71
-1 353.43
-1 091.75
-3 854.16
EBITDA margin %
-655.02
-913.66
-1 297.16
-1 000.3
-3 459.99
Net margin %
-638.97
-944.62
-1 329.06
-1 155.03
-4 304.57
Liquidity ratios
Quick ratio
15.02
8.96
7.37
0.58
2.14
Current ratio
15.15
9.25
7.59
0.93
3.91
Inventory turnover
1.78
1.37
0.69
0.29
0.2
Asset turnover
0.04
0.05
0.05
0.08
0.15
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
0
0.01
0.15
0
0.89
Long term debt to total equity ratio
0
0.01
0.23
0
6.98
Per share metrics
Operating cash flow per share
-1.18
-0.91
-0.73
-0.87
-0.7
EBIT per share
-1.24
-0.98
-0.94
-0.8
-0.65
EBITDA per share
-1.15
-0.93
-0.9
-0.73
-0.59
Total debt per share
—
—
—
—
—
Cash per share
3.69
1.1
1.41
0.16
0.53
Net current asset value per share
3.82
1.2
1.51
0.36
1.36
Tangible book value per share
3.92
1.29
1.19
0.1
0.34
Working capital per share
3.57
1.07
1.31
-0.03
-0.05
Book value per share
3.92
1.29
1.19
0.1
0.35
新闻
Femasys receives CPT code approval for infertility treatment
Femasys-Aktie steigt nach Ankündigung einer Vertriebspartnerschaft in der Schweiz
Femasys expands European presence with Swiss distribution deal
Femasys: NASDAQ verlängert Frist zur Erfüllung der Mindestkurspflicht um 180 Tage
Femasys granted 180-day extension by Nasdaq to meet minimum bid price rule
Femasys: Partnerschaft mit Refuah Health Center soll FemaSeed-Fertilitätsbehandlung ausweiten
Femasys partners with Refuah Health Center to expand FemaSeed fertility treatment
Jonathan Schechter buys PharmaCyte Biotech shares worth $48,232
Pharmacyte Biotech CEO Silverman buys $80k in shares
Femasys receives FDA clearance for FemVue Controlled diagnostic device
PharmaCyte-Aktie haussiert nach erfolgreichem Verkauf von Femasys-Beteiligung
PharmaCyte Biotech stock soars after successful Femasys stake sale